Phase 1 Platelet Transfusion Refractoriness Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia

The First Affiliated Hospital of Soochow University9 enrolled1 locationNCT07072247

Recruiting

Phase 1Phase 2

Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

Platelet Transfusion Refractoriness

Keymed Biosciences Co.Ltd110 enrolled1 locationNCT06792019